Thoraflex™ Hybrid THP3038X150ARecalls & reported problems
Vascutek Ltd · Thoraflex Hybrid Plexus 4 Hybrid Stent Device · Class 3 · Implant
All models of Thoraflex Hybrid (33)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05037881026855), received between Sep 5, 2024 and Mar 11, 2025 — classified as 1 death, 1 injury.
The most frequently reported specific device problem is “Deformation Due to Compressive Stress” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Deformation Due to Compressive Stress1
- Insufficient Device Problem Information1
Patient problems
- Ruptured Aneurysm2
- Adult Respiratory Distress Syndrome1
- Insufficient Information1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
DeathMar 11, 2025Deformation Due to Compressive Stress; Deformation Due to Compressive Stress
THE COMPONENT THAT THE DEVICE DEFICIENCY WAS REPORTED IS TO BE RELATED TO A THORAFLEX HYBRID DEVICE. THORAFLEX HYBRID PROCEDURE TOOK PLACE ON (B)(6)2024. THE ASCENDING AORTIC GRAFT FROM THE PREVIOUS SURGERY WAS THEN TRIMMED, AND THE PROXIMAL THORAFLEX GRAFT (30MM) TRIMMED AND BEVELLED TO FIT THIS. A PLANNED AORTIC VALVE PROCEDURE WAS ALSO CARRIED OUT. AN ENDOLEAK WAS REPORTED AS BEING PRESENT AT THE END OF THE PROCEDURE. NO ADVERSE EVENTS OR DEVICE DEFICIENCIES WERE REPORTED AT THE TIME OF THE PROCEDURE. NO ISSUES WERE REPORTED ON THE POST THORAFLEX HYBRID PROCEDURE ASSESSMENT. THE SUBJECT UNDERWENT THE EXTENSION PROCEDURE DURING THE SAME HOSPITAL ADMISSION. THE EXTENSION PROCEDURE WAS REPORTED TO HAVE TAKEN PLACE ON THE (B)(6)2024 (VARIOUS DEVICE ARE LISTED: 2 X GORE CTAG, 3 X GORE VIABAHN). NO ENDOLEAK WAS REPORTED AT THE END OF THE PROCEDURE BUT THE DEVICE DEFICIENCY KINKING/ TWISTING WAS REPORTED. PATIENT OUTCOME: THE SUBJECT IS REPORTED TO HAVE DIED ON (B)(6)2024. NO AUTOPSY WAS PERFORMED. THE PRIMARY CAUSE OF DEATH WAS CATEGORISED AS "DISEASE UNDER STUDY".
Patient problems: Adult Respiratory Distress Syndrome; Insufficient Information; Ruptured Aneurysm
MAUDE report 21570723 ↗InjurySep 5, 2024Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
THE INDICATION FOR SURGERY WAS AN AORTIC ANEURYSM AND DISSECTION WITH A TYPE 2 ENDOLEAK IN THE DESCENDING THORACIC AORTA. SHAPE OF THE ANEURYSM AND DEBAKEY TYPE. AN ELECTIVE THORAFLEX HYBRID PLEXUS WAS PERFORMED ON (B)(6) 2024. THE ASCENDING AORTIC GRAFT FROM THE PREVIOUS SURGERY WAS THEN TRIMMED, AND THE PROXIMAL THORAFLEX GRAFT (30MM) TRIMMED AND BEVELLED TO FIT THIS. AT THE POST INDEX PROCEDURE ASSESSMENT THE GRAFT WAS PATENT WITH NO THORAFLEX HYBRID DEVICE DEFORMATIONS. ON THE (B)(6) 2024, 6 DAYS POST INDEX PROCEDURE, A COMPUTED TOMOGRAPHY ANGIOGRAPHY SCAN WAS PERFORMED WHICH SHOWED A LEAKING THORACOABDOMINAL AORTIC ANEURYSM (TAAA). THE PATIENT WAS EXAMINED BY CARDIOVASCULAR SURGEON AND DEEMED A CANDIDATE FOR EMERGENCY ENDOVASCULAR TAAA REPAIR USING PARALLEL ENDOGRAFTS. SURGERY WAS PERFORMED -TEVAR WITH PARALLEL GRAFTS FOR CELIAC, SPINAL MUSCULAR ATROPHY, AND LEFT RENAL VIA RIGHT FEMORAL AND LEFT COMMON CAROTID CUTDOWNS. THE SITE HAVE DEEMED THIS TO BE AN UNANTICIPATED EVENT, WHICH IS NOT RELATED TO THE PROCEDURE OR THE DEVICE BUT RELATED TO A PRE-EXISTING CONDITION. THE MEDICAL MONITOR WHO OVERSEES THE SAFETY OF THE STUDY HAS DEEMED THIS EVENT TO BE POSSIBLY RELATED TO THE DEV
Patient problems: Ruptured Aneurysm
MAUDE report 20146488 ↗
Other Hybrid stent graft, thoracic aortic lesion treatment devices
- Thoraflex™ Hybrid THP3032X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment3 deaths8 reports
- Thoraflex™ Hybrid THP3036X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment7 reports
- Thoraflex™ Hybrid THP3032X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment4 reports
- Thoraflex™ Hybrid THA3036X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment4 reports
- Thoraflex™ Hybrid THP2830X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment4 reports
- Thoraflex™ Hybrid THP3036X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment1 death3 reports
- Thoraflex™ Hybrid THA3032X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment2 deaths3 reports
- Thoraflex™ Hybrid THA2830X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment1 death3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page